Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host
Cancer Cell · 2025-01 · 43 (1) · 144-160.e7
DOI: 10.1016/j.ccell.2024.11.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2025-01. Verfasst von Maria F Gonzalez-Aponte und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO 63130, USA. Hauptthemen laut MEDLINE: Glioblastoma, Circadian Rhythm, Glucocorticoids, Brain Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults with a poor prognosis despite aggressive therapy. Here, we hypothesized that daily host signaling regulates tumor growth and synchronizes circadian rhythms in GBM. We find daily glucocorticoids promote or suppress GBM growth through glucocorticoid receptor (GR) signaling depending on time of day and the clock genes, Bmal1 and Cry. Blocking circadian signals, like vasoactive intestinal peptide or glucocorticoids, dramatically slows GBM growth and disease progression. Analysis of human GBM samples from The Cancer Genome Atlas (TCGA) shows that high GR expression significantly increases hazard of mortality. Finally, mouse and human GBM models have intrinsic circadian rhythms in clock gene expression in vitro and in vivo that entrain to the host through glucocorticoid signaling, regardless of tumor type or host immune status. We conclude that GBM entrains to the circadian circuit of the brain, modulating its growth through clock-controlled cues, like glucocorticoids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO 63130, USA.
- Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA; Siteman Cancer Center Biostatistics Shared Resource, Division of Public Health Sciences, Dep…
- Department of Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Department of Biology, Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO 63130, USA. Electronic address: herzog@wustl.edu.
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Gonzalez-Aponte, M. F., Damato, A. R., Simon, T., Aripova, N., Darby, F., Jeon, M. S., Luo, J., Rubin, J. B., & Herzog, E. D. (2025). Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host. Cancer Cell, 43(1), 144-160.e7. https://doi.org/10.1016/j.ccell.2024.11.012
Vancouver
Gonzalez-Aponte MF, Damato AR, Simon T, Aripova N, Darby F, Jeon MS, et al. Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host. Cancer Cell. 2025;43(1):144-160.e7. doi:10.1016/j.ccell.2024.11.012
BibTeX
@article{GonzalezAponte2025,
author = {Gonzalez-Aponte, Maria F and Damato, Anna R and Simon, Tatiana and Aripova, Nigina and Darby, Fabrizio and Jeon, Myung Sik and Luo, Jingqin and Rubin, Joshua B and Herzog, Erik D},
title = {Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {1},
pages = {144--160.e7},
doi = {10.1016/j.ccell.2024.11.012}
}
EUVIMED